A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer - Original Article
Favorite
Share
More Options
8

Open in WPS to view all 8 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
